DurhamTreated old mice grew muscle fibres 45% larger than untreated controls.
Aged stem cells run low on glutaminase, limiting the lipids they need to grow; Duke researchers replenished palmitate and oleate outside the body before reimplanting.
David Lee of the Duke team said clinical trials are the next step.
Sources: New Scientist
THE HIDDEN POPULATION
Beneath every muscle fiber's outer membrane sits a quiet reserve of satellite cells, discovered by Alexander Mauro in 1961. They sleep until the fiber is damaged, then divide — one daughter rebuilds the muscle, the other returns to sleep. This asymmetric split is what lets the reserve last a lifetime.
WHY MUSCLE WITHERS
Sarcopenia is the age-related loss of muscle mass and strength. After age 30, adults lose roughly 3-8% of muscle per decade; after 60, the slope steepens. By 80, a typical person has shed nearly half the muscle they had at 30 — which is why falls become lethal, not just inconvenient.
THE METABOLIC LOCK
Aged satellite cells do not just divide more slowly — they lose the metabolic machinery to build new membrane. Glutaminase converts glutamine into the carbon skeletons cells use to synthesize fatty acids. Without enough of it, the cell cannot make the lipids a new muscle fiber's membrane requires.
PALMITATE AND OLEATE
These are the two most abundant fatty acids in mammalian cell membranes — palmitate is saturated (16 carbons), oleate is monounsaturated (18 carbons, one double bond). Together they set membrane fluidity. The Duke approach bypasses the broken glutaminase step by feeding the cells the end products directly.
THE TRANSLATION PROBLEM
Mouse muscle regenerates faster than human muscle at every age — a young mouse can rebuild a damaged tibialis in two weeks; a young human takes months. Many regeneration therapies that work spectacularly in mice deliver modest effects in human trials. The 45% figure is a starting point, not a forecast.
WHY THIS MATTERS
Sarcopenia is not cosmetic. Grip strength predicts all-cause mortality in adults over 60 better than blood pressure does. Muscle is also the body's largest glucose sink — losing it accelerates insulin resistance. A working sarcopenia therapy would be a metabolic intervention as much as a mobility one.